Repurposing FDA-approved drugs can help fight back breast cancer

by Baylor College of MedicineMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumour beyond the lymph node. Credit: Nephron/WikipediaScreening Food and Dr

Updated on: April 07,2024

Repurposing FDA-approved drugs can help fight back breast cancer

by Baylor College of MedicineMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumour beyond the lymph node. Credit: Nephron/WikipediaScreening Food and Dr

Updated on:April 07,2024

Adjuvant therapy for hepatocellular carcinoma after curative treatment: Several unanswered questions

by Xia & He PublishingICI, immune checkpoint inhibitor. Credit: Jian-Hong Zhong, Liang Ma, Le Li, Zhen-Zhen LiHepatocellular carcinoma (HCC) is one of the most prevalent malignancies globally and

Updated on: July 17,2024

Adjuvant therapy for hepatocellular carcinoma after curative treatment: Several unanswered questions

by Xia & He PublishingICI, immune checkpoint inhibitor. Credit: Jian-Hong Zhong, Liang Ma, Le Li, Zhen-Zhen LiHepatocellular carcinoma (HCC) is one of the most prevalent malignancies globally and

Updated on:July 17,2024

Aggressive surgery increases survival with low-grade brain tumors: Study

by University of California, San FranciscoCredit: Unsplash/CC0 Public DomainThe transition of a low-grade, slow growing brain tumor to a lethal one can be delayed if neurosurgeons remove as much

Updated on: February 18,2024

Aggressive surgery increases survival with low-grade brain tumors: Study

by University of California, San FranciscoCredit: Unsplash/CC0 Public DomainThe transition of a low-grade, slow growing brain tumor to a lethal one can be delayed if neurosurgeons remove as much

Updated on:February 18,2024

A cell surface marker for identifying tumor-initiating cells in pancreatic cancer

by Kumamoto UniversityROR1 is a cell surface receptor that promotes hyperproliferation, metastasis, and relapse in PDAC when highly expressed. Suppressing ROR1 reduces PDAC growth. Credit: Masaya

Updated on: February 19,2024

A cell surface marker for identifying tumor-initiating cells in pancreatic cancer

by Kumamoto UniversityROR1 is a cell surface receptor that promotes hyperproliferation, metastasis, and relapse in PDAC when highly expressed. Suppressing ROR1 reduces PDAC growth. Credit: Masaya

Updated on:February 19,2024

New method reveals insights into interplay between immune system and tumors

by Mallory Locklear,Yale UniversitySingle cell genomics reveals multiple human immune cell types in tumors and blood of autologous MISTRG6 PDX mice, including innate immune cell types present in

Updated on: January 13,2024

New method reveals insights into interplay between immune system and tumors

by Mallory Locklear,Yale UniversitySingle cell genomics reveals multiple human immune cell types in tumors and blood of autologous MISTRG6 PDX mice, including innate immune cell types present in

Updated on:January 13,2024

Tracking a rare and dangerous breast cancer

by Angela Spivey,Duke UniversityGayathri Devi, PhD, studies how inflammatory breast cancer cells are able to evade the body’s programmed cell death mechanisms that normally get rid of damaged or

Updated on: April 01,2024

Tracking a rare and dangerous breast cancer

by Angela Spivey,Duke UniversityGayathri Devi, PhD, studies how inflammatory breast cancer cells are able to evade the body’s programmed cell death mechanisms that normally get rid of damaged or

Updated on:April 01,2024

Avoid unnecessary removal of lymph nodes in breast cancer, recommends new study

by Universitätsklinikum HeidelbergRadiation planning CT after axillary lymph node dissection. The arrow shows the clips at the upper border of axillary dissection. No surgical changes are noted behind

Updated on: January 29,2024

Avoid unnecessary removal of lymph nodes in breast cancer, recommends new study

by Universitätsklinikum HeidelbergRadiation planning CT after axillary lymph node dissection. The arrow shows the clips at the upper border of axillary dissection. No surgical changes are noted behind

Updated on:January 29,2024

Breast cancer: An aggressive variant triggers a hunt for cures

by Vittoria D'alessio,Horizon: The EU Research & Innovation MagazineResearchers are making progress finding treatments for a particularly aggressive variant of breast cancer. Credit: Ang

Updated on: January 03,2024

Breast cancer: An aggressive variant triggers a hunt for cures

by Vittoria D'alessio,Horizon: The EU Research & Innovation MagazineResearchers are making progress finding treatments for a particularly aggressive variant of breast cancer. Credit: Ang

Updated on:January 03,2024

New therapy strengthens the immune system's counterattack on skin cancer

by Peter Aagaard Brixen, DTU (Technical University of Denmark)Stained electron micrograph of a T cell. Scientists have shown in laboratory experiments that they are able to create a large number of th

Updated on: July 08,2024

New therapy strengthens the immune system's counterattack on skin cancer

by Peter Aagaard Brixen, DTU (Technical University of Denmark)Stained electron micrograph of a T cell. Scientists have shown in laboratory experiments that they are able to create a large number of th

Updated on:July 08,2024

Smoking is an undertreated risk factor after a cancer diagnosis

by American College of SurgeonsBaseline survey results of a national quality improvement project led by the American College of Surgeons describe the many challenges and missed opportunities thes

Updated on: March 20,2024

Smoking is an undertreated risk factor after a cancer diagnosis

by American College of SurgeonsBaseline survey results of a national quality improvement project led by the American College of Surgeons describe the many challenges and missed opportunities thes

Updated on:March 20,2024

Low-risk, long-term cancer survivors more likely to die of non-cancer causes, study shows

by Jessica M. Scully,Yale UniversityCredit: Unsplash/CC0 Public DomainAdvances in early detection and treatment have vastly improved the long-term survival of people diagnosed with cancer.This i

Updated on: February 23,2024

Low-risk, long-term cancer survivors more likely to die of non-cancer causes, study shows

by Jessica M. Scully,Yale UniversityCredit: Unsplash/CC0 Public DomainAdvances in early detection and treatment have vastly improved the long-term survival of people diagnosed with cancer.This i

Updated on:February 23,2024

New ovarian cancer screening technique shows reduced false negatives compared to CA125 method

by Justin Jackson , Medical XpressGraphical abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101061Researchers at the Department of Obstetrics and Gynecology, Peking

Updated on: February 01,2024

New ovarian cancer screening technique shows reduced false negatives compared to CA125 method

by Justin Jackson , Medical XpressGraphical abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101061Researchers at the Department of Obstetrics and Gynecology, Peking

Updated on:February 01,2024